{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:01:04Z","timestamp":1784689264915,"version":"3.55.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T00:00:00Z","timestamp":1784678400000},"content-version":"vor","delay-in-days":55,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-22-1-0042"],"award-info":[{"award-number":["W81XWH-22-1-0042"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R37CA227984"],"award-info":[{"award-number":["R37CA227984"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"U.S. Department of Health & Human Services | NIH | National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA258766"],"award-info":[{"award-number":["R01CA258766"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Estrogen receptor-positive breast cancer represents a significant proportion of breast cancer brain metastasis but remains understudied. Here we show that FGFR1-amplification, a well-established driver of estrogen receptor-positive breast cancer endocrine resistance, promotes estrogen receptor-positive breast cancer brain metastatic colonization in young and aged female mice, through both canonical FGF2\/FGFR1 signaling and non-canonical NCAM1\/FGFR1 interactions. Astrocytic FGF2-mediated paracrine activation of FGFR1 promotes breast cancer brain metastasis in estrogen-treated young mice, but FGF2 levels and signaling decrease in the brain with aging and estrogen-depletion. Neuronal and astrocytic NCAM1, which remain unchanged in young and aged brains, promote adhesion to neurons, migration, and growth of estrogen receptor-positive cells, suggesting that interactions with astrocytes and neurons facilitate early estrogen receptor-positive breast cancer brain metastasis colonization through FGFR1. Importantly, FDA-approved FGFR inhibitors effectively block early colonization but not late-stage brain metastases, suggesting prevention of FGFR1+ brain metastases as a window of opportunity for FGFR1 inhibitors.<\/jats:p>","DOI":"10.1038\/s41467-026-73726-5","type":"journal-article","created":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:44:33Z","timestamp":1779986673000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Brain FGF2 and NCAM1 contribute to FGFR1-dependent progression of estrogen receptor-positive breast cancer brain metastases"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6310-4155","authenticated-orcid":false,"given":"Morgan S.","family":"Fox","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny A.","family":"Jaramillo-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7188-6158","authenticated-orcid":false,"given":"R. Alejandro","family":"Marquez-Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L. F.","family":"Alvarez-Eraso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0045-549X","authenticated-orcid":false,"given":"Maria J.","family":"Contreras-Z\u00e1rate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trinh C.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaina N.","family":"Barela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella N.","family":"Koliavas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3132-4465","authenticated-orcid":false,"given":"Peter","family":"Kabos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4573-3895","authenticated-orcid":false,"given":"Natalie J.","family":"Serkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9170-3988","authenticated-orcid":false,"given":"Carol A.","family":"Sartorius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7342-390X","authenticated-orcid":false,"given":"Elizabeth A.","family":"Wellberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8392-0800","authenticated-orcid":false,"given":"Diana M.","family":"Cittelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,28]]},"reference":[{"key":"73726_CR1","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1016\/S1474-4422(05)70072-7","volume":"4","author":"ECA Kaal","year":"2005","unstructured":"Kaal, E. C. A., Ni\u00ebl, C. G. J. H. & Vecht, C. J. Therapeutic management of brain metastasis.  Lancet Neurol. 4, 289\u2013298 (2005).","journal-title":"Lancet Neurol."},{"key":"73726_CR2","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3233\/BD-2007-26112","volume":"26","author":"D Palmieri","year":"2006","unstructured":"Palmieri, D. et al. Brain metastases of breast cancer. Breast Dis. 26, 139\u2013147 (2006).","journal-title":"Breast Dis."},{"key":"73726_CR3","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1111\/j.1524-4741.2012.01246.x","volume":"18","author":"PG Morris","year":"2012","unstructured":"Morris, P. G. et al. Limited overall survival in patients with brain metastases from triple negative breast cancer.  Breast J. 18, 345\u2013350 (2012).","journal-title":"Breast J."},{"key":"73726_CR4","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1007\/s10585-017-9871-9","volume":"34","author":"DJ Press","year":"2017","unstructured":"Press, D. J., Miller, M. E., Liederbach, E., Yao, K. & Huo, D. De novo metastasis in breast cancer: occurrence and overall survival stratified by molecular subtype. Clin. Exp. Metastasis 34, 457\u2013465 (2017).","journal-title":"Clin. Exp. Metastasis"},{"key":"73726_CR5","doi-asserted-by":"publisher","first-page":"3271","DOI":"10.1200\/JCO.2009.25.9820","volume":"28","author":"H Kennecke","year":"2010","unstructured":"Kennecke, H. et al. Metastatic behavior of breast cancer subtypes. J. Clin. Oncol. 28, 3271\u20133277 (2010).","journal-title":"J. Clin. Oncol."},{"key":"73726_CR6","doi-asserted-by":"publisher","first-page":"2792","DOI":"10.1016\/j.ejca.2009.06.027","volume":"45","author":"F Heitz","year":"2009","unstructured":"Heitz, F. et al. Triple-negative and HER2-overexpressing breast cancers exhibit an elevated risk and an earlier occurrence of cerebral metastases. Eur. J. Cancer 45, 2792\u20132798 (2009).","journal-title":"Eur. J. Cancer"},{"key":"73726_CR7","doi-asserted-by":"publisher","first-page":"C9","DOI":"10.1530\/ERC-16-0397","volume":"23","author":"I Chatzistamou","year":"2016","unstructured":"Chatzistamou, I. & Kiaris, H. Modeling estrogen receptor-positive breast cancers in mice: is it the best we can do?. Endocr. Relat. Cancer 23, C9\u2013C12 (2016).","journal-title":"Endocr. Relat. Cancer"},{"key":"73726_CR8","doi-asserted-by":"publisher","first-page":"1979","DOI":"10.1200\/JCO.2014.55.4139","volume":"32","author":"GW Sledge","year":"2014","unstructured":"Sledge, G. W. et al. Past, present, and future challenges in breast cancer treatment. J. Clin. Oncol. 32, 1979\u20131986 (2014).","journal-title":"J. Clin. Oncol."},{"key":"73726_CR9","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s43018-023-00525-y","volume":"4","author":"FK Turrell","year":"2023","unstructured":"Turrell, F. K. et al. Age-associated microenvironmental changes highlight the role of PDGF-C in ER(+) breast cancer metastatic relapse. Nat. Cancer 4, 468\u2013484 (2023).","journal-title":"Nat. Cancer"},{"key":"73726_CR10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.steroids.2010.10.010","volume":"76","author":"MS Rothman","year":"2011","unstructured":"Rothman, M. S. et al. Reexamination of testosterone, dihydrotestosterone, estradiol and estrone levels across the menstrual cycle and in postmenopausal women measured by liquid chromatography-tandem mass spectrometry. Steroids 76, 177\u2013182 (2011).","journal-title":"Steroids"},{"key":"73726_CR11","first-page":"584","volume":"45","author":"CK Osborne","year":"1985","unstructured":"Osborne, C. K., Hobbs, K. & Clark, G. M. Effect of estrogens and antiestrogens on growth of human breast cancer cells in athymic nude mice. Cancer Res 45, 584\u2013590 (1985).","journal-title":"Cancer Res"},{"key":"73726_CR12","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1196\/annals.1386.021","volume":"1089","author":"H Offner","year":"2006","unstructured":"Offner, H. & Polanczyk, M. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis. Ann. N. Y Acad. Sci. 1089, 343\u2013372 (2006).","journal-title":"Ann. N. Y Acad. Sci."},{"key":"73726_CR13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0126","author":"E Guerini-Rocco","year":"2021","unstructured":"Guerini-Rocco, E. et al. Genomic aberrations and late recurrence in postmenopausal women with hormone receptor-positive early breast cancer: results from the SOLE trial. Clin. Cancer Res https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-0126 (2021).","journal-title":"Clin. Cancer Res"},{"key":"73726_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1158\/1541-7786.MCR-20-0554","volume":"19","author":"JW DiGiacomo","year":"2021","unstructured":"DiGiacomo, J. W., Godet, I., Trautmann-Rodriguez, M. & Gilkes, D. M. Extracellular matrix-bound FGF2 mediates estrogen receptor signaling and therapeutic response in breast cancer. Mol. Cancer Res 19, 136\u2013149 (2021).","journal-title":"Mol. Cancer Res"},{"key":"73726_CR15","doi-asserted-by":"publisher","first-page":"4871","DOI":"10.1172\/JCI130323","volume":"130","author":"S Garcia-Recio","year":"2020","unstructured":"Garcia-Recio, S. et al. FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease. J. Clin. Invest 130, 4871\u20134887 (2020).","journal-title":"J. Clin. Invest"},{"key":"73726_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09068-2","volume":"10","author":"L Formisano","year":"2019","unstructured":"Formisano, L. et al. Aberrant FGFR signaling mediates resistance to CDK4\/6 inhibitors in ER+ breast cancer. Nat. Commun. 10, 1373 (2019).","journal-title":"Nat. Commun."},{"key":"73726_CR17","doi-asserted-by":"publisher","first-page":"6443","DOI":"10.1158\/1078-0432.CCR-19-0138","volume":"25","author":"JZ Drago","year":"2019","unstructured":"Drago, J. Z. et al. FGFR1 amplification mediates endocrine resistance but retains TORC sensitivity in metastatic hormone receptor-positive (HR(+)) breast cancer. Clin. Cancer Res 25, 6443\u20136451 (2019).","journal-title":"Clin. Cancer Res"},{"key":"73726_CR18","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10549-025-07666-x","volume":"211","author":"K Ding","year":"2025","unstructured":"Ding, K. et al. FGFR4 in endocrine resistance: overexpression and estrogen regulation without direct causative role. Breast Cancer Res Treat. 211, 501\u2013515 (2025).","journal-title":"Breast Cancer Res Treat."},{"key":"73726_CR19","doi-asserted-by":"publisher","DOI":"10.1177\/1758835920915305","volume":"12","author":"N Xie","year":"2020","unstructured":"Xie, N. et al. FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients. Ther. Adv. Med Oncol. 12, 1758835920915305 (2020).","journal-title":"Ther. Adv. Med Oncol."},{"key":"73726_CR20","doi-asserted-by":"publisher","unstructured":"Wellberg, E. A. et al. FGFR1 underlies obesity-associated progression of estrogen receptor-positive breast cancer after estrogen deprivation. JCI Insight. https:\/\/doi.org\/10.1172\/jci.insight.120594 (2018).","DOI":"10.1172\/jci.insight.120594"},{"key":"73726_CR21","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.tins.2017.03.003","volume":"40","author":"V Sytnyk","year":"2017","unstructured":"Sytnyk, V., Leshchyns\u2019ka, I. & Schachner, M. Neural cell adhesion molecules of the immunoglobulin superfamily regulate synapse formation, maintenance, and function. Trends Neurosci. 40, 295\u2013308 (2017).","journal-title":"Trends Neurosci."},{"key":"73726_CR22","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1242\/dev.115568","volume":"142","author":"A Dabrowski","year":"2015","unstructured":"Dabrowski, A., Terauchi, A., Strong, C. & Umemori, H. Distinct sets of FGF receptors sculpt excitatory and inhibitory synaptogenesis. Development 142, 1818\u20131830 (2015).","journal-title":"Development"},{"key":"73726_CR23","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1038\/nature09041","volume":"465","author":"A Terauchi","year":"2010","unstructured":"Terauchi, A. et al. Distinct FGFs promote differentiation of excitatory and inhibitory synapses. Nature 465, 783\u2013787 (2010).","journal-title":"Nature"},{"key":"73726_CR24","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.cell.2004.06.025","volume":"118","author":"H Umemori","year":"2004","unstructured":"Umemori, H., Linhoff, M. W., Ornitz, D. M. & Sanes, J. R. FGF22 and its close relatives are presynaptic organizing molecules in the mammalian brain. Cell 118, 257\u2013270 (2004).","journal-title":"Cell"},{"key":"73726_CR25","doi-asserted-by":"publisher","first-page":"3884","DOI":"10.1007\/s12035-021-02367-0","volume":"58","author":"L Klimaschewski","year":"2021","unstructured":"Klimaschewski, L. & Claus, P. Fibroblast growth factor signalling in the diseased nervous system. Mol. Neurobiol. 58, 3884\u20133902 (2021).","journal-title":"Mol. Neurobiol."},{"key":"73726_CR26","doi-asserted-by":"publisher","first-page":"6057","DOI":"10.1523\/JNEUROSCI.1140-04.2004","volume":"24","author":"Y Ohkubo","year":"2004","unstructured":"Ohkubo, Y., Uchida, A. O., Shin, D., Partanen, J. & Vaccarino, F. M. Fibroblast growth factor receptor 1 is required for the proliferation of hippocampal progenitor cells and for hippocampal growth in mouse. J. Neurosci. 24, 6057\u20136069 (2004).","journal-title":"J. Neurosci."},{"key":"73726_CR27","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/0006-8993(95)01002-X","volume":"701","author":"AM Gonzalez","year":"1995","unstructured":"Gonzalez, A. M., Berry, M., Maher, P. A., Logan, A. & Baird, A. A comprehensive analysis of the distribution of FGF-2 and FGFR1 in the rat brain. Brain Res 701, 201\u2013226 (1995).","journal-title":"Brain Res"},{"key":"73726_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/1756-6606-2-16","volume":"2","author":"DK Ma","year":"2009","unstructured":"Ma, D. K., Ponnusamy, K., Song, M. R., Ming, G. L. & Song, H. Molecular genetic analysis of FGFR1 signalling reveals distinct roles of MAPK and PLCgamma1 activation for self-renewal of adult neural stem cells. Mol. Brain 2, 16 (2009).","journal-title":"Mol. Brain"},{"key":"73726_CR29","doi-asserted-by":"publisher","first-page":"4197","DOI":"10.1523\/JNEUROSCI.0436-04.2004","volume":"24","author":"K Cambon","year":"2004","unstructured":"Cambon, K. et al. A synthetic neural cell adhesion molecule mimetic peptide promotes synaptogenesis, enhances presynaptic function, and facilitates memory consolidation. J. Neurosci. 24, 4197\u20134204 (2004).","journal-title":"J. Neurosci."},{"key":"73726_CR30","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1097\/WNR.0b013e3283491682","volume":"22","author":"C Christensen","year":"2011","unstructured":"Christensen, C., Berezin, V. & Bock, E. Neural cell adhesion molecule differentially interacts with isoforms of the fibroblast growth factor receptor. Neuroreport 22, 727\u2013732 (2011).","journal-title":"Neuroreport"},{"key":"73726_CR31","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1111\/j.1471-4159.2005.03284.x","volume":"94","author":"VV Kiselyov","year":"2005","unstructured":"Kiselyov, V. V., Soroka, V., Berezin, V. & Bock, E. Structural biology of NCAM homophilic binding and activation of FGFR. J. Neurochem 94, 1169\u20131179 (2005).","journal-title":"J. Neurochem"},{"key":"73726_CR32","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/S0969-2126(03)00096-0","volume":"11","author":"VV Kiselyov","year":"2003","unstructured":"Kiselyov, V. V. et al. Structural basis for a direct interaction between FGFR1 and NCAM and evidence for a regulatory role of ATP. Structure 11, 691\u2013701 (2003).","journal-title":"Structure"},{"key":"73726_CR33","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1073\/pnas.95.5.2592","volume":"95","author":"LA Krushel","year":"1998","unstructured":"Krushel, L. A., Tai, M. H., Cunningham, B. A., Edelman, G. M. & Crossin, K. L. Neural cell adhesion molecule (N-CAM) domains and intracellular signaling pathways involved in the inhibition of astrocyte proliferation. Proc. Natl. Acad. Sci. USA 95, 2592\u20132596 (1998).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"73726_CR34","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1002\/(SICI)1098-1136(199707)20:3<262::AID-GLIA10>3.0.CO;2-S","volume":"20","author":"S Kobayashi","year":"1997","unstructured":"Kobayashi, S., Vidal, I., Pena, J. D. & Hernandez, M. R. Expression of neural cell adhesion molecule (NCAM) characterizes a subpopulation of type 1 astrocytes in human optic nerve head. Glia 20, 262\u2013273 (1997).","journal-title":"Glia"},{"key":"73726_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.amsu.2014.06.014","volume":"3","author":"EP Weledji","year":"2014","unstructured":"Weledji, E. P. & Assob, J. C. The ubiquitous neural cell adhesion molecule (N-CAM). Ann. Med Surg. (Lond.) 3, 77\u201381 (2014).","journal-title":"Ann. Med Surg. (Lond.)"},{"key":"73726_CR36","doi-asserted-by":"publisher","first-page":"e1001262","DOI":"10.1371\/journal.pbio.1001262","volume":"10","author":"S Knafo","year":"2012","unstructured":"Knafo, S. et al. Facilitation of AMPA receptor synaptic delivery as a molecular mechanism for cognitive enhancement. PLoS Biol. 10, e1001262 (2012).","journal-title":"PLoS Biol."},{"key":"73726_CR37","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1083\/jcb.200303020","volume":"161","author":"I Leshchyns\u2019ka","year":"2003","unstructured":"Leshchyns\u2019ka, I., Sytnyk, V., Morrow, J. S. & Schachner, M. Neural cell adhesion molecule (NCAM) association with PKCbeta2 via betaI spectrin is implicated in NCAM-mediated neurite outgrowth. J. Cell Biol. 161, 625\u2013639 (2003).","journal-title":"J. Cell Biol."},{"key":"73726_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13058-020-01300-y","volume":"22","author":"J Finlay-Schultz","year":"2020","unstructured":"Finlay-Schultz, J. et al. New generation breast cancer cell lines developed from patient-derived xenografts. Breast Cancer Res 22, 68 (2020).","journal-title":"Breast Cancer Res"},{"key":"73726_CR39","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.1158\/0008-5472.CAN-16-3541","volume":"77","author":"J Finlay-Schultz","year":"2017","unstructured":"Finlay-Schultz, J. et al. Breast cancer suppression by progesterone receptors is mediated by their modulation of estrogen receptors and RNA polymerase III. Cancer Res 77, 4934\u20134946 (2017).","journal-title":"Cancer Res"},{"key":"73726_CR40","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1038\/nrd2792","volume":"8","author":"A Beenken","year":"2009","unstructured":"Beenken, A. & Mohammadi, M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 8, 235\u2013253 (2009).","journal-title":"Nat. Rev. Drug Discov."},{"key":"73726_CR41","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/S0092-8674(00)80051-3","volume":"98","author":"AN Plotnikov","year":"1999","unstructured":"Plotnikov, A. N., Schlessinger, J., Hubbard, S. R. & Mohammadi, M. Structural basis for FGF receptor dimerization and activation. Cell 98, 641\u2013650 (1999).","journal-title":"Cell"},{"key":"73726_CR42","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S1097-2765(00)00073-3","volume":"6","author":"J Schlessinger","year":"2000","unstructured":"Schlessinger, J. et al. Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. Mol. Cell 6, 743\u2013750 (2000).","journal-title":"Mol. Cell"},{"key":"73726_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.brainres.2009.11.003","volume":"1309","author":"A Aonurm-Helm","year":"2010","unstructured":"Aonurm-Helm, A., Berezin, V., Bock, E. & Zharkovsky, A. NCAM-mimetic, FGL peptide, restores disrupted fibroblast growth factor receptor (FGFR) phosphorylation and FGFR mediated signaling in neural cell adhesion molecule (NCAM)-deficient mice. Brain Res 1309, 1\u20138 (2010).","journal-title":"Brain Res"},{"key":"73726_CR44","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1083\/jcb.200903030","volume":"187","author":"C Francavilla","year":"2009","unstructured":"Francavilla, C. et al. The binding of NCAM to FGFR1 induces a specific cellular response mediated by receptor trafficking. J. Cell Biol. 187, 1101\u20131116 (2009).","journal-title":"J. Cell Biol."},{"key":"73726_CR45","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1083\/jcb.200109059","volume":"157","author":"P Niethammer","year":"2002","unstructured":"Niethammer, P. et al. Cosignaling of NCAM via lipid rafts and the FGF receptor is required for neuritogenesis. J. Cell Biol. 157, 521\u2013532 (2002).","journal-title":"J. Cell Biol."},{"key":"73726_CR46","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1038\/s41586-019-1576-6","volume":"573","author":"Q Zeng","year":"2019","unstructured":"Zeng, Q. et al. Synaptic proximity enables NMDAR signalling to promote brain metastasis. Nature 573, 526\u2013531 (2019).","journal-title":"Nature"},{"key":"73726_CR47","doi-asserted-by":"publisher","DOI":"10.1101\/2024.01.08.574608","author":"V Venkataramani","year":"2024","unstructured":"Venkataramani, V. et al. Direct excitatory synapses between neurons and tumor cells drive brain metastatic seeding of breast cancer and melanoma. bioRxiv https:\/\/doi.org\/10.1101\/2024.01.08.574608 (2024).","journal-title":"bioRxiv"},{"key":"73726_CR48","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/s41586-025-09492-z","volume":"646","author":"S Savchuk","year":"2025","unstructured":"Savchuk, S. et al. Neuronal activity-dependent mechanisms of small cell lung cancer pathogenesis. Nature 646, 1232\u20131242 (2025).","journal-title":"Nature"},{"key":"73726_CR49","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.1158\/1078-0432.CCR-21-2664","volume":"28","author":"AB Lassman","year":"2022","unstructured":"Lassman, A. B. et al. Infigratinib in Patients with Recurrent Gliomas and FGFR Alterations: A Multicenter Phase II Study. Clin. Cancer Res 28, 2270\u20132277 (2022).","journal-title":"Clin. Cancer Res"},{"key":"73726_CR50","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1016\/j.devcel.2021.03.008","volume":"56","author":"IL Bado","year":"2021","unstructured":"Bado, I. L. et al. The bone microenvironment increases phenotypic plasticity of ER(+) breast cancer cells. Dev. Cell 56, 1100\u20131117 e1109 (2021).","journal-title":"Dev. Cell"},{"key":"73726_CR51","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1158\/0008-5472.CAN-03-1022","volume":"64","author":"ME Ray","year":"2004","unstructured":"Ray, M. E. et al. Genomic and expression analysis of the 8p11-12 amplicon in human breast cancer cell lines. Cancer Res 64, 40\u201347 (2004).","journal-title":"Cancer Res"},{"key":"73726_CR52","doi-asserted-by":"publisher","unstructured":"Voutsadakis, I. A. 8p11.23 Amplification in Breast Cancer: Molecular Characteristics, Prognosis and Targeted Therapy. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm9103079 (2020).","DOI":"10.3390\/jcm9103079"},{"key":"73726_CR53","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nature18268","volume":"533","author":"Q Chen","year":"2016","unstructured":"Chen, Q. et al. Carcinoma-astrocyte gap junctions promote brain metastasis by cGAMP transfer. Nature 533, 493\u2013498 (2016).","journal-title":"Nature"},{"key":"73726_CR54","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1038\/nature15376","volume":"527","author":"L Zhang","year":"2015","unstructured":"Zhang, L. et al. Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth. Nature 527, 100\u2013104 (2015).","journal-title":"Nature"},{"key":"73726_CR55","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.cell.2014.01.040","volume":"156","author":"M Valiente","year":"2014","unstructured":"Valiente, M. et al. Serpins promote cancer cell survival and vascular co-option in brain metastasis. Cell 156, 1002\u20131016 (2014).","journal-title":"Cell"},{"key":"73726_CR56","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/nm.2072","volume":"16","author":"Y Kienast","year":"2010","unstructured":"Kienast, Y. et al. Real-time imaging reveals the single steps of brain metastasis formation. Nat. Med 16, 116\u2013122 (2010).","journal-title":"Nat. Med"},{"key":"73726_CR57","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.1038\/onc.2015.353","volume":"35","author":"CA Sartorius","year":"2016","unstructured":"Sartorius, C. A. et al. Estrogen promotes the brain metastatic colonization of triple negative breast cancer cells via an astrocyte-mediated paracrine mechanism. Oncogene 35, 2881\u20132892 (2016).","journal-title":"Oncogene"},{"key":"73726_CR58","doi-asserted-by":"publisher","first-page":"4685","DOI":"10.1038\/s41388-019-0756-z","volume":"38","author":"MJ Contreras-Zarate","year":"2019","unstructured":"Contreras-Zarate, M. J. et al. Estradiol induces BDNF\/TrkB signaling in triple-negative breast cancer to promote brain metastases. Oncogene 38, 4685\u20134699 (2019).","journal-title":"Oncogene"},{"key":"73726_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/cne.21009","volume":"498","author":"T Chadashvili","year":"2006","unstructured":"Chadashvili, T. & Peterson, D. A. Cytoarchitecture of fibroblast growth factor receptor 2 (FGFR-2) immunoreactivity in astrocytes of neurogenic and non-neurogenic regions of the young adult and aged rat brain. J. Comp. Neurol. 498, 1\u201315 (2006).","journal-title":"J. Comp. Neurol."},{"key":"73726_CR60","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.neuroscience.2016.01.027","volume":"319","author":"C Huang","year":"2016","unstructured":"Huang, C., Yuan, P., Wu, J. & Huang, J. Estrogen regulates excitatory amino acid carrier 1 (EAAC1) expression through sphingosine kinase 1 (SphK1) transacting FGFR-mediated ERK signaling in rat C6 astroglial cells. Neuroscience 319, 9\u201322 (2016).","journal-title":"Neuroscience"},{"key":"73726_CR61","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.brainres.2012.01.056","volume":"1447","author":"M Jurgenson","year":"2012","unstructured":"Jurgenson, M., Aonurm-Helm, A. & Zharkovsky, A. Partial reduction in neural cell adhesion molecule (NCAM) in heterozygous mice induces depression-related behaviour without cognitive impairment. Brain Res 1447, 106\u2013118 (2012).","journal-title":"Brain Res"},{"key":"73726_CR62","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1242\/jcs.010744","volume":"120","author":"C Francavilla","year":"2007","unstructured":"Francavilla, C. et al. Neural cell adhesion molecule regulates the cellular response to fibroblast growth factor. J. Cell Sci. 120, 4388\u20134394 (2007).","journal-title":"J. Cell Sci."},{"key":"73726_CR63","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/s41586-019-1563-y","volume":"573","author":"HS Venkatesh","year":"2019","unstructured":"Venkatesh, H. S. et al. Electrical and synaptic integration of glioma into neural circuits. Nature 573, 539\u2013545 (2019).","journal-title":"Nature"},{"key":"73726_CR64","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1038\/s41586-019-1564-x","volume":"573","author":"V Venkataramani","year":"2019","unstructured":"Venkataramani, V. et al. Glutamatergic synaptic input to glioma cells drives brain tumour progression. Nature 573, 532\u2013538 (2019).","journal-title":"Nature"},{"key":"73726_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-30666-0","volume":"13","author":"RC Coombes","year":"2022","unstructured":"Coombes, R. C. et al. Results of the phase IIa RADICAL trial of the FGFR inhibitor AZD4547 in endocrine resistant breast cancer. Nat. Commun. 13, 3246 (2022).","journal-title":"Nat. Commun."},{"key":"73726_CR66","doi-asserted-by":"publisher","first-page":"6296","DOI":"10.1158\/1538-7445.AM2022-6296","volume":"82","author":"W Knight","year":"2022","unstructured":"Knight, W. et al. Abstract 6296: Preclinical evaluation of a panel of FGFR inhibitors for their normal brain and brain tumor distribution. Cancer Res. 82, 6296\u20136296 (2022).","journal-title":"Cancer Res."},{"key":"73726_CR67","doi-asserted-by":"publisher","DOI":"10.3791\/55085","author":"C Zhang","year":"2017","unstructured":"Zhang, C., Lowery, F. J. & Yu, D. Intracarotid Cancer Cell Injection to Produce Mouse Models of Brain Metastasis. J. Vis. Exp. https:\/\/doi.org\/10.3791\/55085 (2017).","journal-title":"J. Vis. Exp."},{"key":"73726_CR68","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/2045-3701-1-8","volume":"1","author":"C Zhang","year":"2011","unstructured":"Zhang, C. & Yu, D. Microenvironment determinants of brain metastasis. Cell Biosci. 1, 8 (2011).","journal-title":"Cell Biosci."},{"key":"73726_CR69","first-page":"v144","volume":"3","author":"L Miarka","year":"2021","unstructured":"Miarka, L. & Valiente, M. Animal models of brain metastasis. Neurooncol Adv. 3, v144\u2013v156 (2021).","journal-title":"Neurooncol Adv."},{"key":"73726_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2023.148338","volume":"1808","author":"LA Koza","year":"2023","unstructured":"Koza, L. A. et al. Immunocal(R) limits gliosis in mouse models of repetitive mild-moderate traumatic brain injury. Brain Res 1808, 148338 (2023).","journal-title":"Brain Res"},{"key":"73726_CR71","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/neuonc\/noz116","volume":"21","author":"AM Pierce","year":"2019","unstructured":"Pierce, A. M. et al. Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymoma. Neuro Oncol. 21, 1540\u20131551 (2019).","journal-title":"Neuro Oncol."},{"key":"73726_CR72","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/978-1-61779-452-0_4","volume":"814","author":"J de Vellis","year":"2012","unstructured":"de Vellis, J. & Cole, R. Preparation of mixed glial cultures from postnatal rat brain. Methods Mol. Biol. 814, 49\u201359 (2012).","journal-title":"Methods Mol. Biol."},{"key":"73726_CR73","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1111\/j.1471-4159.2006.04369.x","volume":"101","author":"M Pertusa","year":"2007","unstructured":"Pertusa, M., Garcia-Matas, S., Rodriguez-Farre, E., Sanfeliu, C. & Cristofol, R. Astrocytes aged in vitro show a decreased neuroprotective capacity. J. Neurochem 101, 794\u2013805 (2007).","journal-title":"J. Neurochem"},{"key":"73726_CR74","unstructured":"NanoStringNCTools: NanoString nCounter Tools (2024)."},{"key":"73726_CR75","unstructured":"GeomxTools: NanoString GeoMx Tools (2024)."},{"key":"73726_CR76","unstructured":"GeoMxWorkflows: GeoMx Digital Spatial Profiler (DSP) data analysis workflows (2024)."},{"key":"73726_CR77","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1093\/nar\/gkad1026","volume":"52","author":"N Liu","year":"2024","unstructured":"Liu, N. et al. standR: spatial transcriptomic analysis for GeoMx DSP data. Nucleic Acids Res 52, e2 (2024).","journal-title":"Nucleic Acids Res"},{"key":"73726_CR78","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43, e47 (2015).","journal-title":"Nucleic Acids Res"},{"key":"73726_CR79","unstructured":"GeoMXAnalysisWorkflow: GeoMXAnalysisWorkflow (2023)."},{"key":"73726_CR80","unstructured":"msigdb: An ExperimentHub Package for the Molecular Signatures Database (MSigDB) (2024)."},{"key":"73726_CR81","unstructured":"GSEABase: Gene set enrichment data structures and methods (2024)."},{"key":"73726_CR82","unstructured":"vissE: Visualising Set Enrichment Analysis Results (2024)."},{"key":"73726_CR83","unstructured":"igraph: Network Analysis and Visualization in R (2025)."},{"key":"73726_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"73726_CR85","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1038\/nprot.2012.099","volume":"7","author":"GM Beaudoin 3rd","year":"2012","unstructured":"Beaudoin, G. M. 3rd et al. Culturing pyramidal neurons from the early postnatal mouse hippocampus and cortex. Nat. Protoc. 7, 1741\u20131754 (2012).","journal-title":"Nat. Protoc."},{"key":"73726_CR86","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1093\/bioinformatics\/btz760","volume":"36","author":"Y Wang","year":"2020","unstructured":"Wang, Y. et al. SynQuant: an automatic tool to quantify synapses from microscopy images. Bioinformatics 36, 1599\u20131606 (2020).","journal-title":"Bioinformatics"},{"key":"73726_CR87","unstructured":"\u201cThe image stabilizer plugin for ImageJ,\u201d https:\/\/www.cs.cmu.edu\/~kangli\/code\/Image_Stabilizer.html (2008)."},{"key":"73726_CR88","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.ymeth.2016.09.016","volume":"115","author":"JY Tinevez","year":"2017","unstructured":"Tinevez, J. Y. et al. TrackMate: An open and extensible platform for single-particle tracking. Methods 115, 80\u201390 (2017).","journal-title":"Methods"},{"key":"73726_CR89","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41592-022-01507-1","volume":"19","author":"D Ershov","year":"2022","unstructured":"Ershov, D. et al. TrackMate 7: integrating state-of-the-art segmentation algorithms into tracking pipelines. Nat. Methods 19, 829\u2013832 (2022).","journal-title":"Nat. Methods"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73726-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73726-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73726-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T02:02:49Z","timestamp":1784685769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-73726-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,28]]},"references-count":89,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["73726"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-73726-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,28]]},"assertion":[{"value":"26 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.S.F., J.A.J., R.A.M., K.L.F.A., M.J.C., T.C.P., E.N.B., S.N.K., N.J.S., C.A.S., E.A.W.: no conflicts. D.M.C.: Research grant support from Nuvation. PK: Clinical research grant support from Genentech, Menarini, Eli Lilly, AstraZeneca.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"6945"}}